Clearmind Medicine is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Adi Zuloff-Shani, with a market cap of $1.7M.
No upcoming earnings scheduled for Clearmind Medicine
No earnings announcement scheduled
Past 8 earnings reports for Clearmind Medicine
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q1 2026 | -$3.32 | — | - | — | — |
| Feb 3, 2026 | Q4 2025 | — | — | — | — | — |
| Sep 11, 2025 | Q3 2025 | -$0.25 | — | - | — | — |
| Jun 12, 2025 | Q2 2025 | -$0.16 | — | - | — | — |
| Mar 13, 2025 | Q1 2025 | -$0.24 | — | - | — | — |
| Jan 22, 2025 | Q4 2024 | -$0.11 | — | - | — | — |
| Sep 16, 2024 | Q3 2024 | -$0.59 | — | - | — | — |
| Jun 13, 2024 | Q2 2024 | -$0.28 | — | - | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.